GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Addex Therapeutics ADXN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

0.02

+6.93%

Close of 10 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 173,000

FY2016FY2025

Net income

−CHF 6.7m

FY2016FY2025

Free cash flow

−CHF 2.2m

FY2016FY2025

Shareholders' equity

CHF 4.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 173,000CHF 410,042CHF 1.6mCHF 1.4mCHF 2.9mCHF 3.6mCHF 2.8mCHF 6.0mCHF 499,894CHF 17,329
Research and developmentCHF 671,651CHF 594,848CHF 983,527CHF 14.7mCHF 12.8mCHF 10.4mCHF 12.5mCHF 2.4mCHF 841,308CHF 819,330
Operating income−CHF 2.8m−CHF 2.8m−CHF 2.2m−CHF 20.8m−CHF 15.5m−CHF 12.8m−CHF 14.8m−CHF 1.4m−CHF 3.2m−CHF 3.1m
Net income−CHF 6.7mCHF 7.1m−CHF 10.6m−CHF 20.8m−CHF 15.4m−CHF 12.9m−CHF 14.8m−CHF 1.6m−CHF 3.3m−CHF 3.1m
Diluted earnings per share-0.050.07-0.11-0.46-0.45-0.48-0.55-0.06-0.25-0.27

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 6.4mCHF 10.7mCHF 4.6mCHF 8.3mCHF 22.5mCHF 20.2mCHF 33.0mCHF 42.2mCHF 3.1mCHF 1.7m
Cash and short-term investmentsCHF 1.6mCHF 3.3mCHF 3.9mCHF 7.0mCHF 20.5mCHF 18.8mCHF 31.6mCHF 41.7mCHF 2.6mCHF 1.4m
Total liabilitiesCHF 1.6mCHF 1.0mCHF 3.5mCHF 3.4mCHF 5.6mCHF 5.6mCHF 7.5mCHF 3.0mCHF 1.7mCHF 1.5m
DebtCHF 34,688CHF 41,994CHF 344,336CHF 373,135CHF 482,018CHF 567,401CHF 550,245CHF 14,921CHF 10,979—
Shareholders' equityCHF 4.8mCHF 9.7mCHF 1.1mCHF 4.9mCHF 16.9mCHF 14.6mCHF 25.5mCHF 39.2mCHF 1.3mCHF 218,592
Shares outstanding142m98m95m45m34m27m27m27m13m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CHF 2.2m−CHF 5.4m−CHF 8.0m−CHF 16.4m−CHF 14.7m−CHF 12.2m−CHF 9.5mCHF 1.8m−CHF 2.1m−CHF 2.7m
Capital spending—−CHF 1,272−CHF 6,842−CHF 581−CHF 31,549−CHF 59,414−CHF 28,459−CHF 9,054−CHF 697−CHF 11,221
Free cash flow−CHF 2.2m−CHF 5.4m−CHF 8.0m−CHF 16.4m−CHF 14.7m−CHF 12.2m−CHF 9.5mCHF 1.7m−CHF 2.1m−CHF 2.7m
Dividends paid———−CHF 307,496−CHF 390,189—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCHF 10,000CHF 7,691CHF 15,830CHF 29,724CHF 36,375CHF 71,055CHF 1,508CHF 58,347
Operating income−CHF 645,000−CHF 480,000−CHF 779,263−CHF 696,175−CHF 732,898−CHF 606,262−CHF 445,626−CHF 622,199
Net income−CHF 1.7m−CHF 1.7m−CHF 1.8m−CHF 1.6m−CHF 1.8m−CHF 1.5m−CHF 1.2m−CHF 1.5m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.02
Total assets—CHF 4.8mCHF 6.4mCHF 7.3mCHF 8.5mCHF 9.5mCHF 10.7mCHF 12.2m
Cash and short-term investments—CHF 937,500CHF 1.6mCHF 2.2mCHF 2.3mCHF 2.8mCHF 3.3mCHF 3.4m
Debt—CHF 77,241CHF 7,680CHF 36,545CHF 38,391CHF 40,198CHF 41,996CHF 43,765
Shareholders' equity—CHF 3.3mCHF 4.8mCHF 6.0mCHF 7.2mCHF 8.3mCHF 9.7mCHF 11.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-50.5%-45.5%15.7%
Operating income-48.6%-26.1%-3.1%
Net income-31.4%-12.1%4.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-956.8%-790.6%-561.1%-427.6%
Net margin56.0%-857.7%-584.4%-442.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.20.8-0.2-0.1-0.7-1.2-0.8-10.3-2.6-1.9
Price to sales45.613.71.51.73.44.24.52.817.3352.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.